Recombinant Protein Production News and Research

RSS
ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Small peptide TAxI holds promise for carrying biologic drugs into spinal cord

Small peptide TAxI holds promise for carrying biologic drugs into spinal cord

New drug approved by FDA for treatment of von Willebrand disease

New drug approved by FDA for treatment of von Willebrand disease

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

BRI signs license agreement with SOBI for Kineret (anakinra)

BRI signs license agreement with SOBI for Kineret (anakinra)

New oral biologic medication successfully treats precancerous intestinal inflammation

New oral biologic medication successfully treats precancerous intestinal inflammation

Research report on biopharmaceutical and vaccine manufacturing markets

Research report on biopharmaceutical and vaccine manufacturing markets

Genticel provides update on patents granted in the USA and Asia

Genticel provides update on patents granted in the USA and Asia

Delphi Genetics announces new license agreement for use of StabyExpress technology in food industry

Delphi Genetics announces new license agreement for use of StabyExpress technology in food industry

Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion signs definitive asset purchase agreement to acquire EGEN

Researchers discover new therapeutic approach for hemophilia

Researchers discover new therapeutic approach for hemophilia

Recombinant human prion protein stops propagation of prions, say researchers

Recombinant human prion protein stops propagation of prions, say researchers

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

New quick test promises to reduce economic, health burden of syphilis cases in Latin America

New quick test promises to reduce economic, health burden of syphilis cases in Latin America

iBio announces production of vaccine candidate for new H7N9 influenza virus

iBio announces production of vaccine candidate for new H7N9 influenza virus